The lawsuit seeks nationwide restrictions on a common medication for abortion and miscarriage care.

The 5th Circuit Court of Appeal in Louisiana will hear arguments on Wednesday in a case that could decide future telehealth access to mifepristone.

The 5th Circuit will hear Louisiana’s challenge to Biden-era abortion by mail rules as the FDA conducts a new mifepristone safety review.